Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing

Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced it has entered into an option agreement to purchase up to a 15% equity interest in LyoGenesis Plus for cash ...

VECTOR SCIENCE AND THERAPEUTICS CORP

Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased to ...

Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group LLC

Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that it has entered into a development and manufacturing agreement with MPP Group LLC ("MPP"), a Mequon, ...

Vector Science & Therapeutics Expands Board of Directors with Appointment of Dr. Alexander Dobranowski and Scott Kelly

Vector Science & Therapeutics Corp. (TSXV: PAIN) ("Vector" or "Company") today announced the appointment of Dr. Alexander Dobranowski and Scott Kelly to its Board of Directors ("Board"), further ...

/C O R R E C T I O N -- Vector Sciences & Therapeutics/

In the news release, Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group ...
Newswire

Vector Science & Therapeutics Appoints Tabitha Hendren as Director, Engineering and Design

LODI, Wis., Oct. 2, 2025 /CNW/ -- Vector Science & Therapeutics today announced the appointment of Tabitha Hendren as Director, Engineering and Design. Hendren will report to Chief Technology Officer ...
BizTimes

Vector Science & Therapeutics agrees to option to invest in LyoGenesis Plus, gaining access to FDA-registered manufacturing facility

Mequon-based Vector Science & Therapeutics announced that it has entered into an option agreement to purchase up to a 15% ...